PBS News Weekend’s Ali Rogin spoke with KFF Health News contributor Michelle Andrews about what some people with missing limbs consider a disparity in health insurance coverage: Though a knee replacement likely would be covered, a prosthetic knee isn’t always. A prosthetic device can be subject to cost caps and an amputee may be required…
By JEFF GOLDSMITH Jeff wrote this article for Hospitals & Health Networks in the July 5, 1998 edition. He republished it this week on his substack calling it a “27th anniversary edition”. It’s an enlightening piece, but as you read it please ask yourself. What, if anything, has changed, and did anything get better?–Matthew Holt…
Trellis Health emerged from stealth and announced $1.8 million in pre-seed funding. The platform helps women easily access and understand their medical records so they can make better health decisions during pregnancy and throughout their lives. The post New Pregnancy App Launches to Support Mothers Through Birth and Beyond appeared first on MedCity News.
The growth rate of Medicare Advantage patients activity with physicians and outpatient providers early this year was nearly double what the company had expected.
New strategies using predictive analytics are emerging to improve post-acute home healthcare
In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection for remote monitoring technologies. The post Peterson Center on Healthcare: 3 Policy Recommendations for Remote Health Technologies appeared first on MedCity News.
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…
The NYC Health Department released a report highlighting the immigrant contributions to the city’s health
The first Phase 3 results for Eli Lilly’s daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes. The pharmaceutical giant plans global regulatory submissions starting at the end of this year. The post Eli Lilly’s Metabolic Medicine Takes the Lead in the Race to Develop…
This data note analyzes the list of terminated and active awards the Trump Administration recently sent to Congress highlighting to assess the impact on global health awards.